Lantheus has developed a patent for systems and methods that enhance computer-aided display and analysis of nuclear medicine images. The technology allows interactive adjustment of intensity window thresholds for improved visualization, utilizing a nonlinear scaling function for user adjustments. This innovation enables precise adjustment over the full range of intensities while maintaining fidelity. GlobalData’s report on Lantheus gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to GlobalData’s company profile on Lantheus, was a key innovation area identified from patents. Lantheus's grant share as of May 2024 was 46%. Grant share is based on the ratio of number of grants to total number of patents.
Interactive adjustment of intensity window thresholds for nuclear medicine images
A recently granted patent (Publication Number: US11948283B2) discloses a method and system for interactive adjustment of intensity window thresholds for displaying nuclear medicine images. The method involves accessing the image, rendering it according to an initial intensity window, allowing user selection of a subsequent window through graphical controls, and dynamically updating the display based on user adjustments. The system includes a processor and memory with instructions to perform these functions, enabling real-time updates as the user modifies the intensity window.
The method and system described in the patent allow for precise adjustment of intensity window thresholds for nuclear medicine images, particularly bone scan images. By providing a graphical control element with adjustable indicator widgets along a scale, users can select a subsequent intensity window different from the initial one. The nonlinear scaling function used for intensity values ensures accurate representation of pixel intensities, with real-time updates as the user interacts with the controls. Additionally, the normalization factor calculated based on healthy tissue regions helps maintain consistency in intensity levels across the image, enhancing the overall display quality. Overall, this innovation offers a user-friendly and efficient way to interactively adjust intensity windows for optimal visualization of nuclear medicine images, improving diagnostic capabilities in medical imaging applications.
To know more about GlobalData’s detailed insights on Lantheus, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
